Heavy or problematic drug use, heavy and problematic to define? Iceland 23-25 August 2010, Nordic Alcohol and Drug Researchers’ Assembly Ellen J. Amundsen,

Slides:



Advertisements
Similar presentations
The law and drugs – Section 3. What is a drug? A drug can be: Any substance used in the composition of medicine or A substance used to stupefy or poison.
Advertisements

Introduction to Drug Misuse Les Goldman. Objectives Gain basic knowledge of Common current patterns of drug misuse Local referral pathways Available treatments.
REPORT Full report Executive summary Methodology STATISTICAL ANNEX Seizures Drug use Prices Illicit laboratories.
ROLE OF DRUGS Lesson Essential Question: How does drug dependency lead to violent crimes?
1 A prospective follow-up study of pregnant women in Opioid maintenance Treatment (OMT) and their partners: substance use during pregnancy and one year.
It’s about time Tackling substance misuse in older people.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
The development of an Australian drug policy index Assoc Prof Alison Ritter Director, Drug Policy Modelling Program (DPMP) University of New South Wales.
Neonatal Abstinence Syndrome. Risks for developing NAS Opioids – Opiate derivatives, interact with mu-opioid receptor Abstinence syndrome (withdrawal)
Correlates of polydrug use among injection drug users: The role of socioeconomic stress and quality of life Marrero CA, Robles RR, Reyes JC, Matos TD,
Rene Sebena 1, Rafael Mikolajczyk 2, Olga Orosova 3 Affiliations: 1 PJ Safarik University in Kosice, Faculty of Arts, Department of Psychology, Slovak.
GAP Toolkit 5 Training in basic drug abuse data management and analysis Training session 6 Coding open questions.
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Advancing the prevention and treatment of chronic illnesses UCLA Department of Family Medicine Psychoactive Drugs and HIV Steven Shoptaw, PhD UCLA Center.
A Brief History of Drugs An overview of drug policy and use in the United States from the mid-1800s to the present.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
ESPAD – are young Europeans getting more alike? Björn Hibell EMCDDA Conference Identifying Europe's Information needs for effective drug.
Factors associated with fatal overdoses in Oslo Linn Gjersing, Thomas Clausen, Jørgen Bramness, Helge Waal, Stian Biong & Edle Ravndal.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
MRCPsych seminar series Epidemiology of addictive disorders: a brief review Dr Stuart McLaren March 2010.
“Problem, intensive drug use and polydrug use” Introduction Danica Klempova, Scientific Committee meeting, Lisbon, 17 November.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Alcohol Consumption Lydia Gisle Hélène Mimilidis Presentation in the framework of the EHIS workshop, Berlin, September 30, 2010 Improvement of the European.
BELL WORK Write about 1 of the drugs we talked about yesterday and tell me how that drug would alter your life.
Scotland’s Futures Forum. Devising a scale of harm – and then what? Dr Laurence Gruer OBE.
Drug and Alcohol Misuse Dr Mick McKernan. Harm Reduction Philosophy to lessen the dangers drug abuse cause to Individual/society We will never stop drug.
MRCPsych addiction psychiatry seminar series Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Module 1 General introduction to substitution treatment.
Drug Addiction Joint Tutorial 12/06/08.
What Services Are Saying April Shaw March Survey Questions Covered Questions Covered Illicit Drug Use Illicit Drug Use Polydrug Use Polydrug Use.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Drugs and drug treatment An introduction. Harry Shapiro Director of Communications and Information DrugScope.
Epidemiology of addictive disorders: a brief review MRCPsych addiction psychiatry seminar series Dr Stuart McLaren 2 nd March 2012.
DRUGS AND THEIR EFFECTS. What is a Drug? A drug is any substance—solid, liquid or gas— that brings about physical and/or psychological changes in the.
Special patient groups Module 5. Introduction Worldwide, the majority of people in substitute treatment are men between Even they do not form a.
Sida 1 Christmas Shopping 2006 Nordic summary Synovate (Temo, MMI and Vilstrup) and TOY for Nordea Ingela Gabrielsson
Jennifer R. Havens, PhD, MPH Associate Professor
Regular and intensive use of cannabis and related problems: Some results from literature and from the 2002 REITOX reports (CT P1) Roland Simon.
Chapter 5 Drugs.  Drug – natural or synthetic substance used to produce physiological or psychological effects in humans  More than 75% of the evidence.
A Film Ethnography on Subutex Use Pekka Hakkarainen Nordic Alcohol and Drug Researchers’ Assembly Grand Hotel Reykjavik August 23 rd – August 25 th 2010.
 Humans have used drugs of one sort or another for thousands of years -wine was used at least from the time of the early Egyptians -narcotics from 4000.
USAGE OF DRUGS IN EUROPE LSD CANNABIS. ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal.
MRCPsych addiction psychiatry seminar series Policy, guidance and legal framework of addiction treatment Classification of substance use disorders Assessment.
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
ESPAD Report 2015 Results from the European School Survey Project on Alcohol and Other Drugs ESPAD Group Lisbon, 20 September 2016.
Drug addiction: Therapeutic problems in everyday clinical practice
European Questionnaire on Drug Use among Prisoners - EQDP
Reliability & validity issues in European web survey in Czech Republic
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
World Drug Report 2018.
Medication use and misuse among illicit drug users in France Lisbon Addictions 2017 Paper session 31: Spotlight on the misuse of medicines Aurélie Lermenier-Jeannet.
Ludmila Carapinha, Catarina Guerreiro
Comparison of data from WBE with other sources
Svetlana Skurtveit, Ingunn Olea Lund, Jørgen G
Increased methadone dose reduces illicit drug injection among HIV negative methadone clients in Myanmar Sun Tun1,2, B. Vicknasingam2, Darshan Singh2 1.
National findings from the Illicit Drug Reporting System
Drug use among MSM (overview with focus on chemsex)
Figure 1: Drug of choice, ACT,
ASA EG, Moscow Development Manager Jaana Markkula
Drugs Jan 2018.
Beyond drug criminalisation: Why, what and how?
Skopje, 21 November 2017, General Population Survey results– launch
5-3 Drug Control Laws October 8, 2019
Presentation transcript:

Heavy or problematic drug use, heavy and problematic to define? Iceland August 2010, Nordic Alcohol and Drug Researchers’ Assembly Ellen J. Amundsen, The Norwegian Institute for Alcohol and Drug Research

Content Background Existing definitions Existing figures for Europe and the Nordic countries Aspects of a definition Explore a dataset Outline points of discussion for a definition of hard /heavy/problem drug use

Existing definitions, EMCDDA Injecting drug use Long-duration/ regular use of opioids, cocaine and/or amphetamines Problem opioid (heroin) use ---- What is long duration? What is regular use? Should the definition encompass substitution treatment and prescribed opiates? What about other drugs and polydrug use? What about use of benzodiazepines/tranquilizers?

Existing figures European countries 21 presented estimates of overall problem drug use, including Denmark, Sweden and Finland 14 presented estimates of prevalence of injecting drug use, including Denmark and Norway 15 presented estimates of problem opioid use, including Finland (opioids) and Norway (heroin)

Aspects of hard use The type and frequency of drug used Use of treatment and services Harmful consequences: Physical, dependence, social

Study in Arendal, inhabitants Study population. Persons 18 years or older who had used amphetamines, cocaine, heroin or other opiates/opioids last 12 months Estimated to persons 45 interviews Questionnaire content: Drug use (amphetamines, cocaine, heroin, other opiates/opioids + other substances), frequency and amount, severity of dependence scale, use of local services, marginalization.

Results Arendal I One third women, Age 18 to more than 50 Network size: 4 to 500 Ever use: 98 % Amphetamines, cocaine 82 %, heroin 80 %, other opiates or opioids 89 % Injecting: Ever 82 %, last 12 months 69 %, last 30 days 64 % Almost daily use last 12 months: 20 % A, 4 % C, 9 % H, 42 % other O. 27 % used prescribed opiates/opioids daily

Results Arendal II: Five main groups Group 1: Persons who had used acho daily/almost daily the last 12 months, some of which were using prescribed opioids Group 2: Persons (not in group 1) who had used acho 1-3 times a week last 12 months Group 3: Persons (not in group 1 or 2) who had used acho more than 8 times last 30 days Group 4: Persons (not in group 1 or 2 or 3) - young persons with a short history of drug use Group 5: Persons (not in group 1 or 2 or 3) - older persons with a longer history of drug use, who did not use drugs regularly

Points for discussion of a definition of hard drug use Type of drug? Frequency of use? More than 2-3 times a month? Just weekend use? Shall persons in substitution treatment be included? Or just those who in addition use other specific drugs? Use of services? Role of individual dependence scales? Role of marginalization? Role of potential to quit?

Thank you!! Ellen J. Amundsen, The Norwegian Institute for Alcohol and Drug research/SIRUS,

Severity of dependence scale reference period 12 months 1.Did you think your use of (named drug) was out of control? 2.Did the prospect of missing a fix (or dose) or not chasing make you anxious or worried? 3.Did you worry about your use of (named drug)? 4.Did you wish you could stop? 5.How difficult did you find it to stop, or go without (named drug)? 4 point scale for items 1 to 4 (never/almost never, sometimes, often, always/nearly always), for item 5 (not difficult, quite difficult, very difficult, impossible)

Nutt et al A rational scale to assess the harm of drugs of potential misuse 1.Heroin 2.Cocaine 3.Barbiturates 4.Street methadone 5.Alcohol 6.Ketamine 7.Benzodiazepines 8.Amphetamines 9.Tobacco 10.Buprenorphine 11.Cannabis, solvents, 4-MTA, LSD, Methylphenidate, Anabolic steroids, GHB, Ecstacy, Alkyl nitrates, Khat